A detailed history of Swiss National Bank transactions in Amgen Inc stock. As of the latest transaction made, Swiss National Bank holds 1,586,733 shares of AMGN stock, worth $501 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
1,586,733
Previous 1,602,733 1.0%
Holding current value
$501 Million
Previous $456 Million 8.8%
% of portfolio
0.35%
Previous 0.33%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$262.75 - $319.31 $4.2 Million - $5.11 Million
-16,000 Reduced 1.0%
1,586,733 $496 Million
Q1 2024

May 07, 2024

SELL
$268.87 - $324.56 $18.8 Million - $22.7 Million
-70,000 Reduced 4.18%
1,602,733 $456 Million
Q4 2023

Feb 06, 2024

SELL
$255.7 - $288.46 $11.7 Million - $13.2 Million
-45,900 Reduced 2.67%
1,672,733 $482 Million
Q3 2023

Nov 08, 2023

SELL
$218.65 - $271.46 $46.1 Million - $57.2 Million
-210,800 Reduced 10.93%
1,718,633 $462 Million
Q2 2023

Aug 09, 2023

SELL
$214.27 - $253.37 $40.3 Million - $47.7 Million
-188,100 Reduced 8.88%
1,929,433 $428 Million
Q1 2023

May 10, 2023

SELL
$225.79 - $275.2 $12.8 Million - $15.5 Million
-56,500 Reduced 2.6%
2,117,533 $512 Million
Q4 2022

Feb 08, 2023

SELL
$229.03 - $291.01 $32.3 Million - $41 Million
-140,993 Reduced 6.09%
2,174,033 $571 Million
Q3 2022

Nov 09, 2022

SELL
$224.46 - $253.15 $22.7 Million - $25.6 Million
-101,300 Reduced 4.19%
2,315,026 $522 Million
Q2 2022

Aug 09, 2022

SELL
$230.71 - $256.74 $5.38 Million - $5.98 Million
-23,300 Reduced 0.96%
2,416,326 $588 Million
Q1 2022

May 09, 2022

BUY
$219.27 - $242.57 $61.7 Million - $68.2 Million
281,200 Added 13.03%
2,439,626 $590 Million
Q4 2021

Feb 08, 2022

SELL
$198.88 - $227.6 $22.6 Million - $25.8 Million
-113,400 Reduced 4.99%
2,158,426 $486 Million
Q3 2021

Nov 08, 2021

SELL
$212.27 - $248.7 $17.7 Million - $20.7 Million
-83,300 Reduced 3.54%
2,271,826 $483 Million
Q2 2021

Aug 06, 2021

BUY
$233.58 - $259.14 $13.9 Million - $15.4 Million
59,308 Added 2.58%
2,355,126 $574 Million
Q1 2021

May 07, 2021

BUY
$221.91 - $258.6 $6.3 Million - $7.34 Million
28,400 Added 1.25%
2,295,818 $571 Million
Q4 2020

Feb 05, 2021

SELL
$216.38 - $257.67 $7.23 Million - $8.61 Million
-33,400 Reduced 1.45%
2,267,418 $521 Million
Q3 2020

Nov 09, 2020

SELL
$234.65 - $260.95 $7.46 Million - $8.3 Million
-31,800 Reduced 1.36%
2,300,818 $585 Million
Q2 2020

Aug 05, 2020

BUY
$197.81 - $242.74 $5.24 Million - $6.43 Million
26,500 Added 1.15%
2,332,618 $550 Million
Q1 2020

May 08, 2020

BUY
$182.24 - $241.7 $75.6 Million - $100 Million
415,000 Added 21.94%
2,306,118 $468 Million
Q4 2019

Feb 06, 2020

SELL
$189.21 - $243.2 $23.3 Million - $30 Million
-123,300 Reduced 6.12%
1,891,118 $456 Million
Q3 2019

Nov 12, 2019

SELL
$174.11 - $208.62 $2.47 Million - $2.96 Million
-14,208 Reduced 0.7%
2,014,418 $390 Million
Q2 2019

Aug 02, 2019

SELL
$166.7 - $195.41 $16.6 Million - $19.5 Million
-99,800 Reduced 4.69%
2,028,626 $374 Million
Q1 2019

May 10, 2019

BUY
$180.87 - $203.88 $4.4 Million - $4.95 Million
24,300 Added 1.15%
2,128,426 $404 Million
Q4 2018

Feb 13, 2019

SELL
$178.4 - $208.25 $1.46 Million - $1.71 Million
-8,200 Reduced 0.39%
2,104,126 $410 Million
Q3 2018

Nov 08, 2018

SELL
$185.29 - $208.89 $21.4 Million - $24.1 Million
-115,600 Reduced 5.19%
2,112,326 $438 Million
Q2 2018

Aug 09, 2018

BUY
$166.05 - $186.51 $11.5 Million - $13 Million
69,500 Added 3.22%
2,227,926 $411 Million
Q1 2018

May 04, 2018

SELL
$169.43 - $198.0 $90.6 Million - $106 Million
-534,982 Reduced 19.86%
2,158,426 $368 Million
Q4 2017

Feb 07, 2018

SELL
$168.79 - $188.59 $3.19 Million - $3.56 Million
-18,900 Reduced 0.7%
2,693,408 $468 Million
Q3 2017

Nov 03, 2017

BUY
$167.29 - $191.0 $454 Million - $518 Million
2,712,308
2,712,308 $506 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.